BIAF Stock Analysis: Buy, Sell, or Hold?
BIAF - bioAffinity Technologies, Inc. Common Stock
$0.83
-0.01 (-1.60%)
▼
5d:
-1.23%
30d:
-50.6%
90d:
-79.15%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When BIAF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BIAF shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: BIAF shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: BIAF is currently trading at $0.83, which is considered oversold relative to its 30-day fair value range of $0.88 to $1.68.
Technical Outlook: Technically, BIAF is showing sideways momentum. Immediate support is located at $0.78, while resistance sits at $0.87.
Market Sentiment: BIAF has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+622.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BIAF is showing sideways momentum. Immediate support is located at $0.78, while resistance sits at $0.87.
Market Sentiment: BIAF has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+622.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.88 -
$1.68
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 622.9% below Wall St target ($6.00)
Trading Range Analysis
30-Day Trading Range
$0.88 -
$1.68
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.78
Resistance Level
$0.87
Current Trend
Sideways
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.10
Wall Street Target
$6.00
(+622.9%)
Revenue Growth (YoY)
-27.1%
Profit Margin
-280.6%
Share & Embed Analysis
Last updated: July 02, 2026 10:42 PM ET
Data refreshes hourly during market hours. Next update: 11:42 PM
Data refreshes hourly during market hours. Next update: 11:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIAF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 64 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 64 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$144 | 61 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 54 HOLD |
